NO20024381D0 - Behandling av okular hypertensjon og gluakom - Google Patents

Behandling av okular hypertensjon og gluakom

Info

Publication number
NO20024381D0
NO20024381D0 NO20024381A NO20024381A NO20024381D0 NO 20024381 D0 NO20024381 D0 NO 20024381D0 NO 20024381 A NO20024381 A NO 20024381A NO 20024381 A NO20024381 A NO 20024381A NO 20024381 D0 NO20024381 D0 NO 20024381D0
Authority
NO
Norway
Prior art keywords
glaucoma
treatment
ocular hypertension
ocular
hypertension
Prior art date
Application number
NO20024381A
Other languages
English (en)
Other versions
NO20024381L (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/730,830 external-priority patent/US20010034355A1/en
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20024381D0 publication Critical patent/NO20024381D0/no
Publication of NO20024381L publication Critical patent/NO20024381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024381A 2000-03-16 2002-09-13 Preparat for anvendelse ved behandling av okular hypertensjon og gluakom NO20024381L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52757300A 2000-03-16 2000-03-16
US09/730,830 US20010034355A1 (en) 2000-03-16 2000-12-07 Treatment of ocular hypertension
PCT/JP2001/002035 WO2001068072A2 (en) 2000-03-16 2001-03-15 Composition for use in treatment of ocular hypertension and glaucoma

Publications (2)

Publication Number Publication Date
NO20024381D0 true NO20024381D0 (no) 2002-09-13
NO20024381L NO20024381L (no) 2002-11-15

Family

ID=27062443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024381A NO20024381L (no) 2000-03-16 2002-09-13 Preparat for anvendelse ved behandling av okular hypertensjon og gluakom

Country Status (18)

Country Link
US (1) US20010056104A1 (no)
EP (1) EP1272194A2 (no)
JP (1) JP2003526660A (no)
KR (1) KR20080012407A (no)
CN (1) CN100506232C (no)
AR (1) AR029818A1 (no)
AU (2) AU4114301A (no)
BR (1) BR0109192A (no)
CA (1) CA2402597C (no)
CZ (1) CZ20023092A3 (no)
HU (1) HUP0300391A3 (no)
IL (1) IL151683A0 (no)
MX (1) MXPA02008967A (no)
NO (1) NO20024381L (no)
NZ (1) NZ521325A (no)
RU (1) RU2002127733A (no)
TW (1) TWI286932B (no)
WO (1) WO2001068072A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785216B2 (en) † 1995-12-18 2006-06-07 The University of Utah Research Foundation Chomosome 13-linked breast cancer susceptibility gene BRCA2
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
JP2004538306A (ja) * 2001-07-31 2004-12-24 スキャンポ・アーゲー 高眼圧症および緑内障の処置
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850676T2 (de) * 1987-09-18 1994-11-03 R Tech Ueno Ltd Hypotensive okulare Mittel.
ES2186670T3 (es) * 1988-09-06 2003-05-16 Pharmacia Ab Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
TW224942B (no) * 1990-04-04 1994-06-11 Adka Ueno Kk
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
AU1709699A (en) * 1997-12-22 1999-07-12 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
CN1133466C (zh) * 1998-04-07 2004-01-07 阿尔康实验室公司 含有黄原胶的胶凝性眼用组合物

Also Published As

Publication number Publication date
CN1429112A (zh) 2003-07-09
CA2402597C (en) 2011-04-26
AU4114301A (en) 2001-09-24
WO2001068072A2 (en) 2001-09-20
AR029818A1 (es) 2003-07-16
JP2003526660A (ja) 2003-09-09
CN100506232C (zh) 2009-07-01
CZ20023092A3 (cs) 2003-05-14
RU2002127733A (ru) 2004-03-27
EP1272194A2 (en) 2003-01-08
NZ521325A (en) 2004-05-28
KR20080012407A (ko) 2008-02-11
HUP0300391A3 (en) 2008-05-28
MXPA02008967A (es) 2003-02-12
US20010056104A1 (en) 2001-12-27
CA2402597A1 (en) 2001-09-20
NO20024381L (no) 2002-11-15
IL151683A0 (en) 2003-04-10
HUP0300391A2 (hu) 2003-06-28
AU2001241143B2 (en) 2005-08-25
BR0109192A (pt) 2003-05-27
WO2001068072A3 (en) 2002-06-06
TWI286932B (en) 2007-09-21

Similar Documents

Publication Publication Date Title
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
NO20032695L (no) Karboksamidderivater og deres anvendelse ved behandling av tromboemboliskesykdommer
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
NO20015969D0 (no) Forbedret sklerittprotese for behandling av presbyopi og andre öyesykdommer
NO20041345L (no) Kopolymerer for undertrykkelse av autoimmune sykdommer og fremgangsmate for anvendelse
NO20024486L (no) Forbedret behandling av neovaskularisering
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
NO20023678D0 (no) Behandling av allergiske og inflammatoriske tilstander
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
NO20030978D0 (no) Behandling av diuresedysfunksjon
DE60103685D1 (de) Behandlung von Poriomania
AR027832A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
FI20040531A (fi) Insuliiniresistenttien tilojen hoitaminen ja diagnosointi
NO20040059L (no) Benzo[G]kinolinderivater for behandling av glaukom og myopi
AR026062A1 (es) Tratamiento de desordenes oculares
NO20031779L (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
NO20025760D0 (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
EP1416889A4 (en) REDUCED INCISION LENS AND USE THEREOF
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20030767D0 (no) Behandling av forbrenninger
AU2001216038A1 (en) Treatment of glaucoma and ocular hypertension
NO20014476D0 (no) Behandling av hiatial hernia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application